UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Electron-Beam Technology in Microelectronic Fabrication

Brewer, George

1, 1980

Volltextzugriff (PDF)

Early and late effects of levodopa on the cardiovascular system in Parkinson's disease

Journal of the neurological sciences, 1973-05, Vol.19 (1), p.97-103

Ballantyne, J.P.

1973

Volltextzugriff (PDF)

5 - Mask fabrication by electron-beam lithography

Electron-Beam Technology in Microelectronic Fabrication, 1980, p.259-307

BALLANTYNE, J.P.

1980

Volltextzugriff (PDF)

A PROSPECTIVE SURVEY FOR INSULINOMAS IN A NEUROLOGY DEPARTMENT

The Lancet (British edition), 1983-05, Vol.321 (8333), p.1094-1095

1983

Volltextzugriff (PDF)

Early and late effects of levodopa on the cardiovascular system in Parkinson's disease: A paired study

Journal of the neurological sciences, 1973-01, Vol.19 (1), p.97-103

Ballantyne, J.P.

1973

Volltextzugriff (PDF)

Relationship of plasma lipids and lipoprotein concentration to cerebral atherosclerosis and electrocardiographic findings

Journal of the neurological sciences, 1974-10, Vol.23 (2), p.323-329

1974

Volltextzugriff (PDF)

Applications of the electron beam exposure system

IEEE transactions on electron devices, 1975-07, Vol.22 (7), p.393-399

1975

Volltextzugriff (PDF)

An instrument for measurement of thermal thresholds in man

Biosensors, 1987, Vol.3 (6), p.391-401

1987

Volltextzugriff (PDF)

Failure Analysis and Failure Mechanisms of High Voltage (530V) Gated Diode Crosspoint Arrays

24th International Reliability Physics Symposium, 1986, p.120-124

1986

Volltextzugriff (PDF)

Effect of Evolocumab on Coronary Plaque Composition

Journal of the American College of Cardiology, 2018-10, Vol.72 (17), p.2012-2021

2018

Volltextzugriff (PDF)

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-12, Vol.324 (22), p.2268

2020

Volltextzugriff (PDF)

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-12, Vol.316 (22), p.2373

2016

Volltextzugriff (PDF)

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

European heart journal, 2014-04, Vol.35 (15), p.960-968

2014

Volltextzugriff (PDF)

Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial

Clinical cardiology (Mahwah, N.J.), 2018-10, Vol.41 (10), p.1281-1288

2018

Volltextzugriff (PDF)

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

European heart journal, 2014-12, Vol.35 (46), p.3277-3286

2014

Volltextzugriff (PDF)

Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia

Atherosclerosis, 2019-01, Vol.280, p.109-117

2019

Volltextzugriff (PDF)

Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease: A Randomized Controlled Trial

Journal of the American College of Cardiology, 2011-03, Vol.57 (9), p.1111-1119

2011

Volltextzugriff (PDF)

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-02, Vol.16 (1), p.55-65

2016

Volltextzugriff (PDF)

Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)

The American heart journal, 2016-06, Vol.176, p.83-92

2016

Volltextzugriff (PDF)

A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study

Journal of the American Heart Association, 2022-03, Vol.11 (6), p.e024176-e024176

2022

Volltextzugriff (PDF)

ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies

Cardiovascular drugs and therapy, 2012-04, Vol.26 (2), p.181-187

2012

Volltextzugriff (PDF)

Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study

Journal of the American Heart Association, 2017-08, Vol.6 (8), p.n/a

2017

Volltextzugriff (PDF)

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial

JAMA : the journal of the American Medical Association, 2009-03, Vol.301 (11), p.1131

2009

Volltextzugriff (PDF)

Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease

Journal of the American College of Cardiology, 2011-03, Vol.57 (9), p.1111-1119

2011

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(34)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(24)
Humans
(21)
Male
(19)
Female
(18)
Cardiovascular System & Cardiology
(15)
Middle Aged
(15)
Cardiac & Cardiovascular Systems
(14)
Adult
(9)
Aged
(9)
Atherosclerosis
(9)
Double-Blind Method
(8)
Biological And Medical Sciences
(7)
Cardiovascular Disease
(7)
Coronary Artery Disease - Drug Therapy
(7)
Risk Factors
(7)
Statins
(7)
Cholesterol
(6)
Disease Progression
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Electron-Beam Technology in Microelectronic Fabrication

Early and late effects of levodopa on the cardiovascular system in Parkinson's disease

5 - Mask fabrication by electron-beam lithography

A PROSPECTIVE SURVEY FOR INSULINOMAS IN A NEUROLOGY DEPARTMENT

Early and late effects of levodopa on the cardiovascular system in Parkinson's disease: A paired study

Relationship of plasma lipids and lipoprotein concentration to cerebral atherosclerosis and electrocardiographic findings

Applications of the electron beam exposure system

An instrument for measurement of thermal thresholds in man

Failure Analysis and Failure Mechanisms of High Voltage (530V) Gated Diode Crosspoint Arrays

Effect of Evolocumab on Coronary Plaque Composition

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia

Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease: A Randomized Controlled Trial

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN

Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)

A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study

ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies

Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial

Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease

Suchergebnisse filtern